News
PGNY
20.98
-2.65%
-0.57
Progyny Inc. to Report Quarterly and Full Year Financial Results
Reuters · 20h ago
PROGYNY, INC. ANNOUNCES DETAILS FOR ITS FOURTH QUARTER AND FULL YEAR 2025 RESULTS REPORT
Reuters · 20h ago
Is Progyny (PGNY) Mispriced After Recent Share Price Weakness And DCF Upside Potential
Simply Wall St · 3d ago
Progyny is Now Oversold (PGNY)
NASDAQ · 3d ago
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Progyny (PGNY)
TipRanks · 4d ago
Weekly Report: what happened at PGNY last week (0202-0206)?
Weekly Report · 4d ago
Progyny (PGNY) Valuation Check After Mixed Share Price Performance And Elevated P/E Multiple
Simply Wall St · 02/05 09:31
Weekly Report: what happened at PGNY last week (0126-0130)?
Weekly Report · 02/02 09:19
Is Progyny (PGNY) Pricing Reflect Future Growth After Recent Share Price Weakness
Simply Wall St · 02/01 01:23
Quant check on health insurers amid Trump admin's proposal for nearly flat Medicare payment rates
Seeking Alpha · 01/27 11:12
Weekly Report: what happened at PGNY last week (0119-0123)?
Weekly Report · 01/26 09:19
Analyst Upgrades Highlight Client Retention And Diversified Revenue Might Change The Case For Investing In Progyny (PGNY)
Simply Wall St · 01/25 04:34
Assessing Progyny (PGNY) Valuation After Citizens Upgrade And Reinforced Client Retention Narrative
Simply Wall St · 01/22 09:48
Progyny price target raised to $35 from $30 at BTIG
TipRanks · 01/21 12:20
PROGYNY INC <PGNY.O>: BTIG RAISES TARGET PRICE TO $35 FROM $30
Reuters · 01/21 11:27
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
Reuters · 01/21 08:26
Progyny (PGNY) Stock Is Up, What You Need To Know
Barchart · 01/20 14:32
Forecasting The Future: 6 Analyst Projections For Progyny
Benzinga · 01/20 14:01
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 01/20 11:28
Progyny Raised to Market Outperform From Market Perform by Citizens
Dow Jones · 01/20 10:32
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.